We believe in helping people who are struggling with serious and debilitating diseases.
Learn More About UsSCIENCE
Delivering On
Unmet Needs
Unmet Needs
Every day we tackle tough challenges in science and medicine. Our teams work diligently to develop smart options that will enable healthcare providers to offer safe and effective treatments for devastating illnesses.
AMYOTROPHIC LATERAL SCLEROSIS
Our Relentless Commitment
Many people living with amyotrophic lateral sclerosis (ALS) have unmet medical needs. We are committed to doing our best to find solutions that may help address those needs.
Sep 30, 2024
Mitsubishi Tanabe Pharma America Presents Open-Label Extension Outcomes and Additional Data from Phase 3 BouNDless Trial of Investigational ND0612 in Parkinson’s Disease
Read More
Sep 27, 2024
Mitsubishi Tanabe Pharma America to Highlight Data on Investigational ND0612 at the 2024 International Congress of Parkinson’s Disease and Movement Disorders
Read More
Sep 17, 2024
Mitsubishi Tanabe Pharma America to Showcase RADICAVA ORS® (edaravone) Presentations at 2024 Neuromuscular Study Group Annual Meeting
Read More
Sep 12, 2024
Mitsubishi Tanabe Pharma America to Present Latest Neurodegenerative Research at the 2024 American Neurological Association 149th Annual Meeting
Read More
You are leaving this website, hosted by Mitsubishi Tanabe Pharma America, Inc.
This link will take you to a website to which our Privacy Policy and Terms of Use does
not apply. Mitsubishi Tanabe Pharma America, Inc. does not control the content of this third-party site.